Patients Breaking Bipolar I disorder stigma in the Hispanic community For many Hispanic patients and families, that is where the gap between need and treatment can begin.
Patients Durability and earlier access could reshape diabetic retinop... This year’s World Sight Day turns global attention to the scale of preventable vision loss
Patients Rare diseases, real opportunity: Why the UK’s next challenge... The UK has the science, the talent, and the investment. The next step is ensuring that innovation translates into timely patient impact.
Patients Maintenance: The underexamined half of the GLP-1 story GLP-1 treatments have historically had an exit problem, as appetite suppression stops when the medication stops.
Patients Why patient safety doesn't end at approval Once a treatment becomes available to the public, protecting patient safety remains a priority throughout its time on the market.
Patients Redefining the self-care pathway in the evolving hayfever la... When it comes to hayfever, proactive approach improves patient health literacy and empowers individuals to put their health back in their own hands.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
